Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 21839251)

1.

Levosimendan for primary graft failure after heart transplantation: a 3-year follow-up.

Beiras-Fernandez A, Kur F, Kaczmarek I, Frisch P, Weis M, Reichart B, Weis F.

Transplant Proc. 2011 Jul-Aug;43(6):2260-2. doi: 10.1016/j.transproceed.2011.05.021.

PMID:
21839251
2.

Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.

Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B.

J Card Fail. 2007 Aug;13(6):417-21.

PMID:
17675054
3.

[The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].

Paksoy F, Ulaş T, Tursun I, Dal MS, Oztekin E, Borlu F.

Anadolu Kardiyol Derg. 2012 Feb;12(1):16-22. doi: 10.5152/akd.2012.004. Epub 2012 Jan 4. Turkish.

4.

Primary graft failure and Ca2+ sensitizers after heart transplantation.

Beiras-Fernandez A, Weis FC, Kur F, Kaczmarek I, Schmoeckel M, Weis M, Reichart B.

Transplant Proc. 2008 May;40(4):951-2. doi: 10.1016/j.transproceed.2008.03.106.

PMID:
18555087
5.

Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation.

Santise G, D'Ancona G, Falletta C, Pirone F, Sciacca S, Turrisi M, Biondo D, Pilato M.

Interact Cardiovasc Thorac Surg. 2009 Sep;9(3):476-9. doi: 10.1510/icvts.2009.202085. Epub 2009 Jun 29.

6.

Cost-effectiveness of levosimendan in patients with acute heart failure.

Fedele F, D'Ambrosi A, Bruno N, Caira C, Brasolin B, Mancone M.

J Cardiovasc Pharmacol. 2011 Oct;58(4):363-6. doi: 10.1097/FJC.0b013e318224e0a2.

PMID:
21697728
7.

Levosimendan reversing low output syndrome after heart transplantation.

Petäjä LM, Sipponen JT, Hämmäinen PJ, Eriksson HI, Salmenperä MT, Suojaranta-Ylinen RT.

Ann Thorac Surg. 2006 Oct;82(4):1529-31.

PMID:
16996977
8.

Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.

Follath F.

Ital Heart J. 2003 May;4 Suppl 2:34S-38S.

PMID:
14635368
9.

Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.

Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A.

Eur J Cardiothorac Surg. 2009 Dec;36(6):1024-30. doi: 10.1016/j.ejcts.2009.05.001. Epub 2009 Jul 9.

PMID:
19592266
10.

Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.

Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W.

Eur J Anaesthesiol. 2008 Aug;25(8):627-33. doi: 10.1017/S0265021508004080. Epub 2008 Apr 11.

PMID:
18405408
11.

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

Moiseyev VS, Põder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI; RUSSLAN Study Investigators.

Eur Heart J. 2002 Sep;23(18):1422-32.

PMID:
12208222
12.

Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.

Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE.

Intensive Care Med. 2012 Jul;38(7):1198-204. doi: 10.1007/s00134-012-2564-6. Epub 2012 Apr 18.

PMID:
22527079
13.

Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.

Lechner E, Moosbauer W, Pinter M, Mair R, Tulzer G.

Pediatr Crit Care Med. 2007 Jan;8(1):61-3.

PMID:
17149153
14.

Early institution of mechanical support improves outcomes in primary cardiac allograft failure.

Marasco SF, Esmore DS, Negri J, Rowland M, Newcomb A, Rosenfeldt FL, Bailey M, Richardson M.

J Heart Lung Transplant. 2005 Dec;24(12):2037-42. Epub 2005 Oct 3.

PMID:
16364846
15.

Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.

Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.

Hellenic J Cardiol. 2007 Mar-Apr;48(2):80-8.

16.

Early experience with Levosimendan in children with ventricular dysfunction.

Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS.

Pediatr Crit Care Med. 2006 Sep;7(5):445-8. Erratum in: Pediatr Crit Care Med. 2007 Mar;8(2):197.

PMID:
16885788
17.
18.

Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.

Lahtinen P, Pitkänen O, Pölönen P, Turpeinen A, Kiviniemi V, Uusaro A.

Crit Care Med. 2011 Oct;39(10):2263-70. doi: 10.1097/CCM.0b013e3182227b97.

PMID:
21666445
19.

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.

Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A.

Eur J Heart Fail. 2009 Mar;11(3):304-11. doi: 10.1093/eurjhf/hfn045. Epub 2009 Jan 21.

20.

Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study.

Bocchi EA, Vilas-Boas F, Moreira Mda C, Barretto AC, Lage S, Albuquerque D, Baima J, Rassi S, Ribeiro JP; Investigators of BELIEF Study; Heart Failure Working Group of Brazilian Society of Cardiology.

Arq Bras Cardiol. 2008 Mar;90(3):182-90. English, Portuguese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk